108 related articles for article (PubMed ID: 36927963)
1. Incident diabetes in course of antiretroviral therapy.
Taramasso L; Squillace N; Ricci E; Menzaghi B; Orofino G; Socio GV; Molteni C; Martinelli CV; Madeddu G; Vichi F; Valsecchi L; Celesia BM; Maggi P; Rusconi S; Pellicanò GF; Cascio A; Sarchi E; Gulminetti R; Falasca K; Di Biagio A; Bonfanti P;
AIDS; 2023 Jul; 37(8):1269-1276. PubMed ID: 36927963
[TBL] [Abstract][Full Text] [Related]
2. Risk of Incident Diabetes Mellitus, Weight Gain, and Their Relationships With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among Persons With Human Immunodeficiency Virus in the United States and Canada.
Rebeiro PF; Jenkins CA; Bian A; Lake JE; Bourgi K; Moore RD; Horberg MA; Matthews WC; Silverberg MJ; Thorne J; Mayor AM; Lima VD; Palella FJ; Saag MS; Althoff KN; Gill MJ; Wong C; Klein MB; Crane HM; Marconi VC; Shepherd BE; Sterling TR; Koethe JR
Clin Infect Dis; 2021 Oct; 73(7):e2234-e2242. PubMed ID: 32936919
[TBL] [Abstract][Full Text] [Related]
3. Diabetes mellitus burden among people living with HIV from the Asia-Pacific region.
Han WM; Jiamsakul A; Kiertiburanakul S; Ng OT; Sim BL; Sun LP; Van Nguyen K; Choi JY; Lee MP; Wong WW; Kamarulzaman A; Kumarasamy N; Zhang F; Tanuma J; Do CD; Chaiwarith R; Merati TP; Yunihastuti E; Pujari S; Ditangco R; Khusuwan S; Ross J; Avihingsanon A;
J Int AIDS Soc; 2019 Jan; 22(1):e25236. PubMed ID: 30697944
[TBL] [Abstract][Full Text] [Related]
4. Integrase Inhibitor Use Associated with Weight Gain in Women and Incident Diabetes Mellitus.
Asundi A; Olson A; Jiang W; Varshney SP; White LF; Sagar M; Lin NH
AIDS Res Hum Retroviruses; 2022 Mar; 38(3):208-215. PubMed ID: 34877881
[TBL] [Abstract][Full Text] [Related]
5. Incidence of cardiometabolic outcomes among people living with HIV-1 initiated on integrase strand transfer inhibitor versus non-integrase strand transfer inhibitor antiretroviral therapies: a retrospective analysis of insurance claims in the United States.
Rebeiro PF; Emond B; Rossi C; Bookhart BK; Shah A; Caron-Lapointe G; Lafeuille MH; Donga P
J Int AIDS Soc; 2023 Jun; 26(6):e26123. PubMed ID: 37306118
[TBL] [Abstract][Full Text] [Related]
6. Weight Gain and Incident Diabetes Among HIV-Infected Veterans Initiating Antiretroviral Therapy Compared With Uninfected Individuals.
Herrin M; Tate JP; Akgün KM; Butt AA; Crothers K; Freiberg MS; Gibert CL; Leaf DA; Rimland D; Rodriguez-Barradas MC; Ruser CB; Herold KC; Justice AC
J Acquir Immune Defic Syndr; 2016 Oct; 73(2):228-36. PubMed ID: 27171741
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for incident diabetes mellitus among HIV-infected patients receiving combination antiretroviral therapy in Taiwan: a case-control study.
Lo YC; Chen MY; Sheng WH; Hsieh SM; Sun HY; Liu WC; Wu PY; Wu CH; Hung CC; Chang SC
HIV Med; 2009 May; 10(5):302-9. PubMed ID: 19220492
[TBL] [Abstract][Full Text] [Related]
8. Weight changes after antiretroviral therapy initiation in CoRIS (Spain): a prospective multicentre cohort study.
Martínez-Sanz J; Blanco JR; Muriel A; Pérez-Elías MJ; Rubio-Martín R; Berenguer J; Peraire J; Bernal E; Martínez OJ; Serrano-Villar S; Moreno S;
J Int AIDS Soc; 2021 May; 24(5):e25732. PubMed ID: 34036745
[TBL] [Abstract][Full Text] [Related]
9. Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium.
Byonanebye DM; Polizzotto MN; Neesgaard B; Sarcletti M; Matulionyte R; Braun DL; Castagna A; de Wit S; Wit F; Fontas E; Vehreschild JJ; Vesterbacka J; Greenberg L; Hatleberg C; Garges H; Gallant J; Volny Anne A; Öllinger A; Mozer-Lisewska I; Surial B; Spagnuolo V; Necsoi C; van der Valk M; Mocroft A; Law M; Ryom L; Petoumenos K;
HIV Med; 2022 Sep; 23(8):895-910. PubMed ID: 35233903
[TBL] [Abstract][Full Text] [Related]
10. Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment.
Capeau J; Bouteloup V; Katlama C; Bastard JP; Guiyedi V; Salmon-Ceron D; Protopopescu C; Leport C; Raffi F; Chêne G;
AIDS; 2012 Jan; 26(3):303-14. PubMed ID: 22089377
[TBL] [Abstract][Full Text] [Related]
11. Antiretroviral drug class and anaemia risk in the current treatment era among people living with HIV in the USA: a clinical cohort study.
Harding BN; Whitney BM; Nance RM; Crane HM; Burkholder G; Moore RD; Mathews WC; Eron JJ; Hunt PW; Volberding P; Rodriguez B; Mayer K; Saag MS; Kitahata MM; Heckbert SR; Delaney JAC
BMJ Open; 2020 Mar; 10(3):e031487. PubMed ID: 32198297
[TBL] [Abstract][Full Text] [Related]
12. Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium.
Bansi-Matharu L; Phillips A; Oprea C; Grabmeier-Pfistershammer K; Günthard HF; De Wit S; Guaraldi G; Vehreschild JJ; Wit F; Law M; Wasmuth JC; Chkhartishvili N; d'Arminio Monforte A; Fontas E; Vesterbacka J; Miro JM; Castagna A; Stephan C; Llibre JM; Neesgaard B; Greenberg L; Smith C; Kirk O; Duvivier C; Dragovic G; Lundgren J; Dedes N; Knudsen A; Gallant J; Vannappagari V; Peters L; Elbirt D; Sarcletti M; Braun DL; Necsoi C; Mussini C; Muccini C; Bolokadze N; Hoy J; Mocroft A; Ryom L
Lancet HIV; 2021 Nov; 8(11):e711-e722. PubMed ID: 34555326
[TBL] [Abstract][Full Text] [Related]
13. Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women.
Justman JE; Benning L; Danoff A; Minkoff H; Levine A; Greenblatt RM; Weber K; Piessens E; Robison E; Anastos K
J Acquir Immune Defic Syndr; 2003 Mar; 32(3):298-302. PubMed ID: 12626890
[TBL] [Abstract][Full Text] [Related]
14. Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.
Petoumenos K; Worm SW; Fontas E; Weber R; De Wit S; Bruyand M; Reiss P; El-Sadr W; Monforte AD; Friis-Møller N; Lundgren JD; Law MG;
J Int AIDS Soc; 2012 Oct; 15(2):17426. PubMed ID: 23078769
[TBL] [Abstract][Full Text] [Related]
15. Risk of Cardiovascular Events in People with HIV (PWH) Treated with Integrase Strand-Transfer Inhibitors: The Debate Is Not Over; Results of the SCOLTA Study.
Corti N; Menzaghi B; Orofino G; Guastavigna M; Lagi F; Di Biagio A; Taramasso L; De Socio GV; Molteni C; Madeddu G; Salomoni E; Pellicanò GF; Pontali E; Bellagamba R; Celesia BM; Cascio A; Sarchi E; Gulminetti R; Calza L; Maggi P; Cenderello G; Bandera A; Carleo MA; Falasca K; Ferrara S; Martini S; Guadagnino G; Angioni G; Bargiacchi O; Ricci ED; Squillace N; Bonfanti P
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675955
[TBL] [Abstract][Full Text] [Related]
16. Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium.
Neesgaard B; Greenberg L; Miró JM; Grabmeier-Pfistershammer K; Wandeler G; Smith C; De Wit S; Wit F; Pelchen-Matthews A; Mussini C; Castagna A; Pradier C; d'Arminio Monforte A; Vehreschild JJ; Sönnerborg A; Anne AV; Carr A; Bansi-Matharu L; Lundgren JD; Garges H; Rogatto F; Zangerle R; Günthard HF; Rasmussen LD; Necsoi C; van der Valk M; Menozzi M; Muccini C; Peters L; Mocroft A; Ryom L
Lancet HIV; 2022 Jul; 9(7):e474-e485. PubMed ID: 35688166
[TBL] [Abstract][Full Text] [Related]
17. New-Onset Diabetes and Antiretroviral Treatments in HIV-Infected Adults in Thailand.
Riyaten P; Salvadori N; Traisathit P; Ngo-Giang-Huong N; Cressey TR; Leenasirimakul P; Techapornroong M; Bowonwatanuwong C; Kantipong P; Nilmanat A; Yutthakasemsunt N; Chutanunta A; Thongpaen S; Klinbuayaem V; Decker L; Le Cœur S; Lallemant M; Capeau J; Mary JY; Jourdain G
J Acquir Immune Defic Syndr; 2015 Aug; 69(4):453-9. PubMed ID: 25886928
[TBL] [Abstract][Full Text] [Related]
18. Incidence and clinical outcomes of diabetes mellitus in HIV-infected adults in Thailand: a retrospective cohort study.
Paengsai N; Jourdain G; Chaiwarith R; Tantraworasin A; Bowonwatanuwong C; Bhakeecheep S; Cressey TR; Mary JY; Salvadori N; Kosachunhanun N
BMC Public Health; 2018 Aug; 18(1):1079. PubMed ID: 30165821
[TBL] [Abstract][Full Text] [Related]
19. Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study.
Serrano-Villar S; Martínez-Sanz J; Ron R; Talavera-Rodríguez A; Fernández-Felix BM; Herrera S; Muriel A; Fanjul F; Portilla J; Muñoz J; Amador C; de Zárraga MA; Vivancos MJ; Moreno S;
Lancet HIV; 2020 Aug; 7(8):e565-e573. PubMed ID: 32763219
[TBL] [Abstract][Full Text] [Related]
20. Changes in body mass index and clinical outcomes after initiation of contemporary antiretroviral regimens.
Bannister WP; Mast TC; de Wit S; Gerstoft J; Wiese L; Milinkovic A; Hadziosmanovic V; Clarke A; Rasmussen LD; Lacombe K; Schommers P; Staub T; Zagalo A; Portu JJ; Tau L; Calmy A; Cavassini M; Gisinger M; Borodulina E; Mocroft A; Reekie J; Peters L;
AIDS; 2022 Dec; 36(15):2107-2119. PubMed ID: 35848573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
